A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis

NCT00293917 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 658

Last updated 2008-02-13

No results posted yet for this study

Summary

A study to assess the long-term safety of tacrolimus cream in the treatment of psoriasis

Conditions

Interventions

DRUG

Tacrolimus Cream

Sponsors & Collaborators

  • Astellas Pharma US, Inc.

    collaborator INDUSTRY
  • Astellas Pharma Inc

    lead INDUSTRY

Principal Investigators

  • M Rico, MD · Astellas Pharma US, Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2007-08-31
Completion
2007-08-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00293917 on ClinicalTrials.gov